Belmont Capital’s Amgen AMGN Stock Holding History

Belmont Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$252K	Hold	902	–	–	0.04%	114
2025 Q1	$281K	Buy	902 +296	+49%	+$87.4K	0.05%	103
2024 Q4	$158K	Sell	606 -533	-47%	-$158K	0.03%	88
2024 Q3	$367K	Buy	1,139 +533	+88%	+$174K	0.06%	89
2024 Q2	$189K	Sell	606 -62	-9%	-$18.2K	0.04%	128
2024 Q1	$190K	Hold	668	–	–	0.05%	93
2023 Q4	$192K	Hold	668	–	–	0.08%	75
2023 Q3	$179K	Buy	668 +604	+944%	+$151K	0.1%	68
2023 Q2	$14.2K	Hold	64	–	–	0.01%	124
2023 Q1	$15.5K	Hold	64	–	–	0.01%	78
2022 Q4	$17K	Hold	64	–	–	0.02%	71
2022 Q3	$14K	Buy	+64	New	+$15.5K	0.02%	64
2021 Q1	–	Sell	-150	Closed	-$34K	–	58
2020 Q4	$34K	Hold	150	–	–	0.02%	32
2020 Q3	$38K	Hold	150	–	–	0.01%	27
2020 Q2	$35K	Hold	150	–	–	0.02%	26
2020 Q1	$30K	Hold	150	–	–	0.03%	23
2019 Q4	$36K	Buy	+150	New	+$33.1K	0.03%	23

Other funds holding AMGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Belmont Capital's AMGN Position: Q2 2025 in Review

Belmont Capital held its Amgen (AMGN) position steady in Q2 2025 at 902 shares worth $252K. The position accounts for 0.04% of the portfolio, ranked #114.

Belmont Capital first reported a position in AMGN in Q4 2019 and has held it in 17 quarters since. The position peaked at $367K in Q3 2024. 2,852 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

Belmont Capital held 902 shares of Amgen worth $252K as of Q2 2025.
Belmont Capital left its Amgen share count unchanged in Q2 2025.
Amgen made up 0.04% of Belmont Capital's portfolio in Q2 2025, its #114 holding.
Belmont Capital first reported a position in Amgen in Q4 2019 and has held it in 17 quarters since.
Belmont Capital's Amgen position peaked at $367K in Q3 2024.
2,852 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on Belmont Capital's 13F filing for Q2 2025, filed 12 Aug 2025.